glp 1 a GLP-1 Medications – Community Education The GLP-1 boom: Challenges, trends,
Description
Paxlovid (nirmatrelvir/ritonavir) Disease area(s): Infectious diseases (antivirals) Manufacturer(s): Pfizer 2024 Sales (USD): $5.72 billion Why it sold so well: In 2024, Pfizers COVID-19 antiviral treatment, Paxlovid, generated $5.72 billion in global revenue, making it the companys third-highest-selling product for the year
PlexusDx yes via the Precision Peptide Genetic Test
GLP-1 Receptor Agonists (Injectable "Weight Loss Shots") Semaglutide (Wegovy): The most commonly requested medication when patients ask if Medicaid covers weight loss shots
Excess adiposity, particularly visceral fat, is associated with metabolic dysfunction that may affect hormone regulation
The growing prevalence of obesity and associated comorbidities, such as diabetes and cardiovascular disorders, has propelled the demand for GLP-1 receptor agonists
And those Bellwether trials will then lay the groundwork for potential resolution or change
